MetLife Investment Management’s Intuitive Surgical ISRG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $45.6M | Sell |
98,878
-3,100
| -3% | -$1.57M | 0.23% | 57 |
|
|
2025
Q4 | $57.8M | Sell |
101,978
-3,842
| -4% | -$2.05M | 0.28% | 44 |
|
|
2025
Q3 | $47.3M | Sell |
105,820
-1,729
| -2% | -$830K | 0.23% | 59 |
|
|
2025
Q2 | $58.4M | Sell |
107,549
-413
| -0.4% | -$216K | 0.34% | 36 |
|
|
2025
Q1 | $53.5M | Sell |
107,962
-1,840
| -2% | -$1.02M | 0.29% | 42 |
|
|
2024
Q4 | $57.3M | Buy |
109,802
+1,500
| +1% | +$781K | 0.31% | 39 |
|
|
2024
Q3 | $53.2M | Sell |
108,302
-2,675
| -2% | -$1.25M | 0.31% | 43 |
|
|
2024
Q2 | $49.4M | Buy |
110,977
+14,095
| +15% | +$5.61M | 0.29% | 46 |
|
|
2024
Q1 | $38.7M | Sell |
96,882
-2,927
| -3% | -$1.11M | 0.26% | 58 |
|
|
2023
Q4 | $33.7M | Sell |
99,809
-1,612
| -2% | -$481K | 0.24% | 67 |
|
|
2023
Q3 | $29.6M | Sell |
101,421
-2,050
| -2% | -$640K | 0.23% | 70 |
|
|
2023
Q2 | $35.4M | Buy |
103,471
+48
| +0% | +$14.5K | 0.26% | 61 |
|
|
2023
Q1 | $26.4M | Sell |
103,423
-1,772
| -2% | -$437K | 0.19% | 91 |
|
|
2022
Q4 | $27.9M | Sell |
105,195
-3,299
| -3% | -$804K | 0.21% | 83 |
|
|
2022
Q3 | $20.3M | Sell |
108,494
-1,693
| -2% | -$364K | 0.17% | 96 |
|
|
2022
Q2 | $22.1M | Sell |
110,187
-2,950
| -3% | -$692K | 0.17% | 98 |
|
|
2022
Q1 | $34.1M | Buy |
113,137
+34,267
| +43% | +$10M | 0.22% | 80 |
|
|
2021
Q4 | $28.3M | Sell |
78,870
-1,698
| -2% | -$584K | 0.23% | 75 |
|
|
2021
Q3 | $26.7M | Sell |
80,568
-1,794
| -2% | -$602K | 0.24% | 79 |
|
|
2021
Q2 | $25.2M | Sell |
82,362
-1,797
| -2% | -$504K | 0.22% | 84 |
|
|
2021
Q1 | $20.7M | Sell |
84,159
-1,491
| -2% | -$375K | 0.19% | 92 |
|
|
2020
Q4 | $23.4M | Sell |
85,650
-3,366
| -4% | -$836K | 0.22% | 78 |
|
|
2020
Q3 | $21.1M | Sell |
89,016
-2,484
| -3% | -$558K | 0.23% | 76 |
|
|
2020
Q2 | $17.4M | Buy |
91,500
+2,127
| +2% | +$381K | 0.2% | 93 |
|
|
2020
Q1 | $14.8M | Sell |
89,373
-2,736
| -3% | -$501K | 0.2% | 98 |
|
|
2019
Q4 | $18.2M | Sell |
92,109
-1,986
| -2% | -$372K | 0.19% | 97 |
|
|
2019
Q3 | $16.9M | Sell |
94,095
-1,374
| -1% | -$238K | 0.19% | 102 |
|
|
2019
Q2 | $16.7M | Sell |
95,469
-2,163
| -2% | -$371K | 0.18% | 103 |
|
|
2019
Q1 | $18.6M | Sell |
97,632
-339
| -0.3% | -$60.3K | 0.2% | 96 |
|
|
2018
Q4 | $15.6M | Sell |
97,971
-1,296
| -1% | -$220K | 0.19% | 97 |
|
|
2018
Q3 | $19M | Sell |
99,267
-789
| -0.8% | -$140K | 0.19% | 90 |
|
|
2018
Q2 | $16M | Sell |
100,056
-1,332
| -1% | -$203K | 0.19% | 100 |
|
|
2018
Q1 | $14M | Sell |
101,388
-2,619
| -3% | -$365K | 0.16% | 116 |
|
|
2017
Q4 | $12.7M | Buy |
+104,007
| New | +$13M | 0.14% | 135 |
|
Other funds holding ISRG
VCM
VPM
MetLife Investment Management's ISRG Position: Q1 2026 in Review
MetLife Investment Management reduced its Intuitive Surgical (ISRG) stake by 3% in Q1 2026, selling an estimated $1.57M and leaving 98,878 shares worth $45.6M. The position accounts for 0.23% of the portfolio, ranked #57.
MetLife Investment Management first reported a position in ISRG in Q4 2017 and has held it in 34 quarters since. The position peaked at $58.4M in Q2 2025. 2,304 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.
- MetLife Investment Management held 98,878 shares of Intuitive Surgical worth $45.6M as of Q1 2026.
- MetLife Investment Management sold 3,100 Intuitive Surgical shares in Q1 2026, an estimated $1.57M.
- Intuitive Surgical made up 0.23% of MetLife Investment Management's portfolio in Q1 2026, its #57 holding.
- MetLife Investment Management first reported a position in Intuitive Surgical in Q4 2017 and has held it in 34 quarters since.
- MetLife Investment Management's Intuitive Surgical position peaked at $58.4M in Q2 2025.
- 2,304 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.
Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.